Andrew McKibben | executive |
Christopher Peetz | executive |
Peter Radovich | executive |
Eric Bjerkholt | executive |
Lili Nsongo | analyst |
Brian Skorney | analyst |
Antonio Arce | analyst |
Good afternoon, ladies and gentlemen. Thank you for joining today's Mirum Pharmaceuticals Reports Q4 [ Year-End ] and 2023 Financial Results and provides business update. My name is [ Tia ], and I will be your moderator for today's call. [Operator Instructions] It is my pleasure to pass the call over to Andrew McKibbin, Vice President of Investor Relations and Finance. Please proceed.